Verify Life Science LLC (CA, USA), health and life sciences company under Alphabet, recently announced its partnerships with four major pharmaceutical companies to allow them to move into the clinical trial market.
An isobaric labeling technique has been developed to amplify signals for comprehensive quantitative phosphoproteomic characterization of small cells populations.
Global leaders in life sciences and nonclinical drug development, Envigo (Huntingdon, UK) and LabCorp (NC, USA), have signed an innovative agreement in a bid to expand nonclinical drug development capabilities and create an independent research models provider.
Researchers have developed a novel technology to test for viral infections by detecting small amounts of antibodies in the blood.
A prototype wearable device has been developed to continuously collect live cancer cells directly from a patient’s blood, presenting an alternative to biopsies.
Take a look at our overview of the top events in the world of bioanalysis for April, May and June 2019.
Electron paramagnetic resonance has been used to measure in-cell distances between spin labels with higher sensitivity than previously seen for conversional methods.
Researchers have discovered a difference between radiation-sensitive and radiation-resistant tumors that could be utilized to assess tumor response, potentially sparing some patients of the toxic side effects of ineffective radiation therapy.
You are cordially invited to join us in New Orleans for an exclusive masquerade ball celebrating all things bioanalysis!
A new microfluidics device has been developed that could detect individual cancer cells in blood and has the potential to be used for liquid biopsies.